Maternal antibiotic use Maternal antibiotic use during pregnancy may increase the likelihood of ASD, with 1.11.5-fold increases in the risk of ASD reported across several international cohorts after prenatal antibiotic exposure [12, 124, 125]
J Chem Ecol 39:14001406
the active ingredient portion of a composition of the disclosure comprises at least about 0.001 %, at least about 0.002 %, at least about 0.003 %, at least about 0.004 %, at least about 0.005 %, at least about 0.006 %, at least about 0.007 %, at least about 0.008 %, at least about 0.009 %, at least about 0.01 %, at least about 0.011, at least about 0.012 %, at least about 0.013 %, at least about 0.014 %, at least about 0.015 %, at least about 0.016 %, at least about 0.017 %, at least about 0.018 %, at least about 0.019 %, at least about 0.02 %, at least about 0.021 %, at least about 0.022 %, at least about 0.023 %, at least about 0.024 %, at least about 0.025 %, at least about 0.026 %, at least about a composition comprises between about 0.1 mg and about 100 mg of antioxidant (e.g
In some of these non-selenium-containing GPxs (which often function as thioredoxin-dependent peroxidases), the active-site Cys is also deprotonated, suggesting a redox-active site
